Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mahmoud M. A. Elsayed"'
Autor:
Mahmoud A. Hashem, Badriyah S. Alotaibi, Mahmoud M. A. Elsayed, Manal E. Alosaimi, Amal K. Hussein, Maram H. Abduljabbar, Kyung-Tae Lee, Hamdy Abdelkader, Mohamed A. El-Mokhtar, Ahmed H.E. Hassan, Amany A. Abdel-Rheem, Amany Belal, Mohammed S. Saddik
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2423 (2023)
Wound healing is a significant healthcare problem that decreases the patient’s quality of life. Hence, several agents and approaches have been widely used to help accelerate wound healing. The challenge is to search for a topical delivery system th
Externí odkaz:
https://doaj.org/article/2d0bdabb9c69401a9856bdb64f152975
Autor:
Mostafa F. Al-Hakkani, Nourhan Ahmed, Alaa A. Abbas, Mohammad H. A. Hassan, Hossameldin A. Aziz, Ali M. Elshamsy, Hazim O. Khalifa, Mohamed A. Abdelshakour, Mohammed S. Saddik, Mahmoud M. A. Elsayed, Marwa A. Sabet, Mohamed A. El-Mokhtar, Mosa Alsehli, M. S. Amin, Ahmed M. Abu-Dief, Hamada H. H. Mohammed
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14818 (2023)
A novel derivative of ciprofloxacin (Cpx) was synthesized and characterized using various analytical techniques, including FT-IR spectroscopy, UV-Vis spectroscopy, TEM and SEM analysis, 1H NMR, 13C NMR, and HPLC analysis. The newly prepared Cpx deriv
Externí odkaz:
https://doaj.org/article/6a5fe4f20e87462f92acc9d89c4d7923
Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer
Autor:
Ahmed A. El-Shenawy, Mahmoud M. A. Elsayed, Gamal M. K. Atwa, Mohammed A. S. Abourehab, Mohamed S. Mohamed, Mohammed M. Ghoneim, Reda A. Mahmoud, Shereen A. Sabry, Walid Anwar, Mohamed El-Sherbiny, Yasser A. Hassan, Amany Belal, Abd El hakim Ramadan
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 680 (2023)
Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and breast cancer. GFT exhibits low solubility and hence low oral bioavailability, which restricts
Externí odkaz:
https://doaj.org/article/edf3bae5918948f491e4770af7add1d3
Autor:
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Amany A. Abdel-Rheem, Mohamed A. El-Mokhtar, Eisa S. Mosa, Mostafa F. Al-Hakkani, Samah A. Al-Shelkamy, Ali Khames, Mohamed A. Daha, Jelan A. Abdel-Aleem
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1845 (2022)
High mortality and morbidity rates are related to hepatocellular carcinoma (HCC), which is the most prevalent type of liver cancer. A new vision for cancer treatment and cancer cell targeting has emerged with the application of nanotechnology, which
Externí odkaz:
https://doaj.org/article/32cdac25f27c4ea99611c53eb909d6b8
Autor:
Mahmoud M. A. Elsayed, Moustafa O. Aboelez, Mohamed S. Mohamed, Reda A. Mahmoud, Ahmed A. El-Shenawy, Essam A. Mahmoud, Ahmed A. Al-Karmalawy, Eman Y. Santali, Sameer Alshehri, Mahmoud Elkot Mostafa Elsadek, Mohamed A. El Hamd, Abd El hakim Ramadan
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1629 (2022)
Hyperlipidemia is still the leading cause of heart disease in patients with hypertension. The purpose of this study is to make rosuvastatin calcium (ROS) and atenolol (AT) bilayer tablets to treat coexisting dyslipidemia and hypertension with a singl
Externí odkaz:
https://doaj.org/article/ed3d840321ea41b296a642d297400de6
Autor:
Mahmoud M. A. Elsayed
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 56 (2021)
Tolmetin sodium (TS) is a powerful non-steroidal mitigating drug for the treatment of rheumatoid joint inflammation, osteoarthritis, and adolescent rheumatoid joint pain. In addition to its gastrointestinal (GIT) problems, TS has a short biological h
Externí odkaz:
https://doaj.org/article/25046f963d9f4ca1977602a7eb5fd1f5
Autor:
Mahmoud M. A. Elsayed, Moustafa O. Aboelez, Bakheet E. M. Elsadek, Hatem A. Sarhan, Khaled Ali Khaled, Amany Belal, Ahmed Khames, Yasser A. Hassan, Amany A. Abdel-Rheem, Eslam B. Elkaeed, Mohamed Raafat, Mahmoud Elkot Mostafa Elsadek
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 880 (2022)
Tolmetin sodium (TLM) is a non-steroidal anti-inflammatory drug (NSAIDs). TLM is used to treat inflammation, skeletal muscle injuries, and discomfort associated with bone disorders. Because of the delayed absorption from the gastro intestinal tract (
Externí odkaz:
https://doaj.org/article/3dc7f5c3722a4acea8777a442cc0f54e
Autor:
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Mohamed A. El-Mokhtar, Haitham Sedky, Jelan A. Abdel-Aleem, Ahmed M. Abu-Dief, Mostafa F. Al-Hakkani, Hazem L. Hussein, Samah A. Al-Shelkamy, Fatma Y. Meligy, Ali Khames, Heba A. Abou-Taleb
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 111 (2022)
Skin is the largest mechanical barrier against invading pathogens. Following skin injury, the healing process immediately starts to regenerate the damaged tissues and to avoid complications that usually include colonization by pathogenic bacteria, le
Externí odkaz:
https://doaj.org/article/f847180c61304d89b9052267516dd2e6
Autor:
Mahmoud M. A. Elsayed, Tarek M. Okda, Gamal M. K. Atwa, Gamal A. Omran, Atef E. Abd Elbaky, Abd El hakim Ramadan
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 648 (2021)
Luteolin (LUT) is a natural flavonoid with low oral bioavailability with restricted clinical applications due to its low solubility. LUT shows significant anti-tumor activity in many cancer cells, including hepatocellular carcinoma (HCC). The most re
Externí odkaz:
https://doaj.org/article/1c2a726a5367469da032672fa0d79543
Autor:
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Mohamed Salaheldin A. Abdelkader, Mohamed A. El-Mokhtar, Jelan A. Abdel-Aleem, Ahmed M. Abu-Dief, Mostafa F. Al-Hakkani, Hatem S. Farghaly, Heba A. Abou-Taleb
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 226 (2021)
Colorectal cancer (CRC) is the third highest major cause of morbidity and mortality worldwide. Hence, many strategies and approaches have been widely developed for cancer treatment. This work prepared and evaluated the antitumor activity of 5-Fluorou
Externí odkaz:
https://doaj.org/article/4ebcbc57ec6a4fd4a98ec9a959ff4292